Poll: Patient and Staff Safety

For the initial treatment of pediatric multiple sclerosis, do you choose to treat your patients with newer or injectable disease-modifying therapies?

The proposed product standard by the FDA aims to reduce the number of youth and young adult smokers, while improving the health of those who do smoke. Do you believe this proposal will make an impact? ...

Which questionnaire do you prefer to administer to patients when measuring the impact of their COPD on their quality of life? Let us know by taking our poll.

A recent study highlighted the barriers to therapy for patients with HIV/HCV coinfection. Have you experienced barriers to your patients receiving HCV therapy? Voice your opinion via our latest poll!

Creating an initial drug regimen for patients with recently diagnosed HIV can be difficult, and using dual-drug therapy as initial antiretroviral therapy may be controversial. Do you think dual-drug therapy...